New Times,
New Thinking.

  1. Business
  2. Economics
6 October 2011

QE2 has set sail

Bank of England begins more quantitative easing, described by Osborne as "the last resort of despera

By George Eaton

As expected, the Bank of England has fired the starting gun on a second round of quantitative easing [the creation of electronic money to purchase government bonds and other assets], boosting the current £200bn asset purchase scheme by £75bn.

Insofar as the government has a plan B, this is it. As George Osborne said in his speech to the Conservative conference, he and David Cameron are “fiscal conservatives and monetary activists”, and the Chancellor came as close as possible to endorsing another round of QE while respecting the Bank of England’s independence. But the move, which will inevitably fuel inflation, will appall those conservatives raised on Nigel Lawson’s tight monetary policies.

Yet faced with the fact that the economy hasn’t grown for nine months, it’s no surprise that Osborne has approved another round of QE. A recent study by the Bank of England concluded that the last programme, which purchased assets equivalent to 14 per cent of GDP, boosted growth by as much as 2 per cent [the equivalent of a 1.5-3 per cent cut in interest rates].

Finally, it would be remiss not to note that in 2009, Osborne described QE as the “last resort of desperate governments when all other policies have failed.”

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines